TY  - GEN
AU  - Hu-Lieskovan,Siwen
AU  - Lisberg,Aaron
AU  - Zaretsky,Jesse M
AU  - Grogan,Tristan R
AU  - Rizvi,Hira
AU  - Wells,Daniel K
AU  - Carroll,James
AU  - Cummings,Amy
AU  - Madrigal,John
AU  - Jones,Benjamin
AU  - Gukasyan,Jacklin
AU  - Shintaku,I Peter
AU  - Slamon,Dennis
AU  - Dubinett,Steven
AU  - Goldman,Jonathan W
AU  - Elashoff,David
AU  - Hellmann,Matthew D
AU  - Ribas,Antoni
AU  - Garon,Edward B
TI  - Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer
SN  - 1557-3265
PY  - 2020///0819
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents, Immunological
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Neoplasm Grading
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Treatment Outcome
KW  - Exome Sequencing
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-18-4275
ER  -